170 related articles for article (PubMed ID: 35114134)
1. Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose.
Lawhn-Heath C; Hope TA; Martinez J; Fung EK; Shin J; Seo Y; Flavell RR
Lancet Oncol; 2022 Feb; 23(2):e75-e87. PubMed ID: 35114134
[TBL] [Abstract][Full Text] [Related]
2. Patient dosimetry in radionuclide therapy: the whys and the wherefores.
Thierens HM; Monsieurs MA; Bacher K
Nucl Med Commun; 2005 Jul; 26(7):593-9. PubMed ID: 15942479
[TBL] [Abstract][Full Text] [Related]
3. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Garin E; Tselikas L; Guiu B; Chalaye J; Edeline J; de Baere T; Assenat E; Tacher V; Robert C; Terroir-Cassou-Mounat M; Mariano-Goulart D; Amaddeo G; Palard X; Hollebecque A; Kafrouni M; Regnault H; Boudjema K; Grimaldi S; Fourcade M; Kobeiter H; Vibert E; Le Sourd S; Piron L; Sommacale D; Laffont S; Campillo-Gimenez B; Rolland Y;
Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):17-29. PubMed ID: 33166497
[TBL] [Abstract][Full Text] [Related]
4. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy.
DeNardo GL; Siantar CL; DeNardo SJ
Cancer Biother Radiopharm; 2002 Feb; 17(1):107-18. PubMed ID: 11915167
[TBL] [Abstract][Full Text] [Related]
5. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
[TBL] [Abstract][Full Text] [Related]
6. Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
Brans B; Bodei L; Giammarile F; Linden O; Luster M; Oyen WJG; Tennvall J
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):772-786. PubMed ID: 17268773
[TBL] [Abstract][Full Text] [Related]
7. Preclinical animal research on therapy dosimetry with dual isotopes.
Konijnenberg MW; de Jong M
Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1(Suppl 1):S19-27. PubMed ID: 21484379
[TBL] [Abstract][Full Text] [Related]
8. Options for radionuclide therapy: from fixed activity to patient-specific treatment planning.
Thomas SR
Cancer Biother Radiopharm; 2002 Feb; 17(1):71-82. PubMed ID: 11915175
[TBL] [Abstract][Full Text] [Related]
9. [Radionuclide therapy for cancer--what's new?].
Hanna M; Mikko T
Duodecim; 2012; 128(21):2209-16. PubMed ID: 23210283
[TBL] [Abstract][Full Text] [Related]
10. Radionuclide therapy beyond radioiodine.
Gabriel M
Wien Med Wochenschr; 2012 Oct; 162(19-20):430-9. PubMed ID: 22815123
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide therapy in oncology.
Clarke SE
Cancer Treat Rev; 1994 Jan; 20(1):51-71. PubMed ID: 8293428
[No Abstract] [Full Text] [Related]
12. Horizons in radionuclide therapy: 1985 update.
Beierwaltes WH
J Nucl Med; 1985 Apr; 26(4):421-7. PubMed ID: 3884750
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic advances of nuclear medicine in oncology].
Valdés Olmos RA; Hoefnagel CA; Bais E; Boot H; Taal B; de Kraker J; Vote PA
Rev Esp Med Nucl; 2001 Dec; 20(7):547-57. PubMed ID: 11709141
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry in Peptide radionuclide receptor therapy: a review.
Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
[TBL] [Abstract][Full Text] [Related]
15. Application of MINERVA Monte Carlo simulations to targeted radionuclide therapy.
Descalle MA; Hartmann Siantar CL; Dauffy L; Nigg DW; Wemple CA; Yuan A; DeNardo GL
Cancer Biother Radiopharm; 2003 Feb; 18(1):71-9. PubMed ID: 12667310
[TBL] [Abstract][Full Text] [Related]
16. [Technical methodologic aspects of clinical dosimetry in radionuclide therapy].
Denisenko ON; Ivanov VN; Drozdovskiĭ BIa; Nikulin IuP; Tiatte EG; Ivanova LF; Parshin VS
Med Radiol (Mosk); 1990 Feb; 35(2):48-52. PubMed ID: 2179659
[TBL] [Abstract][Full Text] [Related]
17. Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a 32P/33P radionuclide cocktail.
Lechner A; Blaickner M; Gianolini S; Poljanc K; Aiginger H; Georg D
Phys Med Biol; 2008 Apr; 53(7):1961-74. PubMed ID: 18354241
[TBL] [Abstract][Full Text] [Related]
18. Combining dosimetry for targeted radionuclide and external beam therapies using the biologically effective dose.
Bodey RK; Flux GD; Evans PM
Cancer Biother Radiopharm; 2003 Feb; 18(1):89-97. PubMed ID: 12667312
[TBL] [Abstract][Full Text] [Related]
19. Proceedings of the 1st International Symposium on Radionuclide Therapy and Radiopharmaceutical Dosimetry. September 4-8, 2004, Helsinki, Finland.
Cancer Biother Radiopharm; 2005 Feb; 20(1):41-118. PubMed ID: 15778578
[No Abstract] [Full Text] [Related]
20. [Radionuclide therapy of malignant tumors].
Altenbrunn HJ
Z Gesamte Inn Med; 1978 Jul; 33(14):475-84. PubMed ID: 581247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
